Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Laryngoscope ; 131(11): 2429-2435, 2021 11.
Article in English | MEDLINE | ID: mdl-33864635

ABSTRACT

OBJECTIVES: Sinonasal mucosal melanoma (SNMM) is an aggressive cancer usually managed with surgical resection. This study evaluates the impact of treatment modality and positive surgical margin (PSM) on survival following resection of SNMM. STUDY DESIGN: Retrospective study of a national cancer registry. METHODS: The National Cancer Database was queried for cases of SNMM from 2010 to 2015. Data regarding patient demographics, tumor staging, and treatment modality were obtained. Survival rates were compared by margin status: PSM, negative (NSM), and no operation (0SM) using Kaplan-Meier analysis and log rank test. RESULTS: A total of 446 patients met inclusion criteria. Most cases were elderly (>66 years-old) (67.3%), female (54.3%), and white (89.5%). Cases of SNMM most commonly involved the nasal cavity (81.6%), were Stage 3 (60.0%), and underwent surgical resection at an academic center (65.0%). NSM and PSM were present in 59.0% and 26.9% of cases, respectively, while 14.1% of cases did not undergo surgical resection (0SM). Factors predictive of PSM included resection at a community hospital (OR 2.47) and Stage 4 disease (OR 2.07). The 2-year survival rates were 72.1% (95% CI 69.4-75.4%), 36.3% (95% CI 22.0-48.9), and 16.0% (95% CI 8.2-25.4%) for NSM, PSM and 0SM, respectively. Survival was statistically significant between NSM and PSM (Log rank <0.001) but not between 0SM and PSM (Log rank = 0.062). CONCLUSION: Our study emphasizes the need for NSM for SNMM as PSM did not demonstrate any significant improvement in survival when compared to 0SM. Our findings suggest that cases of SNMM are best managed at academic centers. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:2429-2435, 2021.


Subject(s)
Combined Modality Therapy/methods , Melanoma/mortality , Melanoma/surgery , Survival Rate/trends , Aged , Combined Modality Therapy/statistics & numerical data , Drug Therapy/methods , Female , Humans , Kaplan-Meier Estimate , Male , Margins of Excision , Melanoma/diagnosis , Middle Aged , Nasal Mucosa/pathology , Neoplasm Staging/methods , Paranasal Sinus Neoplasms/ethnology , Paranasal Sinus Neoplasms/pathology , Predictive Value of Tests , Radiotherapy/methods , Retrospective Studies
3.
Head Neck ; 43(4): 1271-1279, 2021 04.
Article in English | MEDLINE | ID: mdl-33368806

ABSTRACT

OBJECTIVE: Metabolic syndrome (MetS) has previously been linked to increased risk of postoperative morbidity and mortality in other surgical undertakings. Because MetS is a consequence of endocrine dysfunction, and given the thyroid's crucial role in endocrine homeostasis, we sought to evaluate the association between MetS and postoperative outcomes of thyroidectomy. METHODS: Data were acquired from the ACS-NSQIP database from years 2005 to 2017. Patients with obesity, diabetes, and hypertension were defined as having MetS. Odds ratios (OR) were obtained for outcomes to quantify risk with multivariate logistic regression. RESULTS: Outcomes significantly affected by MetS included overall complication (OR: 2.00), extended postoperative stay (OR: 1.52), medical complication (OR: 1.48), surgical complication (OR: 1.62), and mortality (OR: 2.33). CONCLUSIONS: Patients with MetS undergoing thyroidectomy are at increased risk of an increased length of stay, overall complications, and mortality.


Subject(s)
Metabolic Syndrome , Humans , Length of Stay , Metabolic Syndrome/complications , Metabolic Syndrome/surgery , Postoperative Complications/epidemiology , Retrospective Studies , Risk Factors , Thyroidectomy/adverse effects
4.
Laryngoscope ; 131(5): 1026-1034, 2021 05.
Article in English | MEDLINE | ID: mdl-32865854

ABSTRACT

OBJECTIVES/HYPOTHESIS: Thyroid cancer with distant metastasis (TCDM) at diagnosis has significantly worse survival rates when compared to localized/regional thyroid cancer. This study sought to report on the characteristics of patients presenting with TCDM and the potential survival advantage of surgical resection. STUDY DESIGN: Data were acquired from the Surveillance, Epidemiology, and End Results (SEER) database with cases from 2004 to 2015. METHODS: TCDM cases (n = 2,558) were identified from the SEER database. The Bonferroni correction was applied for multivariate analysis. Kaplan-Meier analysis was utilized to obtain disease-specific survival (DSS) rates. Cox regression analysis was utilized to identify independent factors significantly associated with survival. RESULTS: The average age of diagnosis of TCDM was 62.0 (±17.5) years. Patients were predominantly white (74.6%), female (54.6%), in a relationship (56.0%), and between ages 36 and 80 years (76.4%). Cases consisted of papillary (57.2%), follicular (16.0%), medullary (8.9%), anaplastic (17.9%) TCDM histological variants. Overall 1-, 5-, and 10-year DSS rates were 72.0%, 56.8%, and 43.8%, respectively. Anaplastic and medullary variants had the worst 10-year DSS (0% and 25.5%, respectively). Patients who underwent surgical resection only and surgical resection with radiation were 49% and 59% less likely to die, respectively. Treatment, age, histology, T staging, relationship status, and metastasis site were determined to be significant predictors of survival. CONCLUSIONS: Surgical resection with radiation was found to be a significant predictor of survival after applying the Bonferroni correction for all thyroid cancer variants except medullary. To increase survival, surgical intervention should be recommended in patients who are deemed to be medically tolerant of surgery. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:1026-1034, 2021.


Subject(s)
Carcinoma/therapy , Thyroid Gland/surgery , Thyroid Neoplasms/therapy , Thyroidectomy/statistics & numerical data , Adult , Aged , Aged, 80 and over , Carcinoma/diagnosis , Carcinoma/mortality , Carcinoma/secondary , Clinical Decision-Making , Female , Humans , Kaplan-Meier Estimate , Male , Middle Aged , Neoplasm Staging , Prognosis , Radiotherapy, Adjuvant/statistics & numerical data , Risk Assessment/statistics & numerical data , SEER Program/statistics & numerical data , Survival Rate , Thyroid Gland/pathology , Thyroid Neoplasms/diagnosis , Thyroid Neoplasms/mortality , Thyroid Neoplasms/pathology , Treatment Outcome , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...